Skip to main content

Recombinant human soluble thrombomodulin in patients with sepsis-associated coagulopathy (SCARLET): an updated meta-analysis.

Publication ,  Journal Article
Yamakawa, K; Levy, JH; Iba, T
Published in: Crit Care
September 5, 2019

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Crit Care

DOI

EISSN

1466-609X

Publication Date

September 5, 2019

Volume

23

Issue

1

Start / End Page

302

Location

England

Related Subject Headings

  • Thrombomodulin
  • Sepsis
  • Humans
  • Emergency & Critical Care Medicine
  • Disseminated Intravascular Coagulation
  • Blood Coagulation Disorders
  • 42 Health sciences
  • 32 Biomedical and clinical sciences
  • 11 Medical and Health Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Yamakawa, K., Levy, J. H., & Iba, T. (2019). Recombinant human soluble thrombomodulin in patients with sepsis-associated coagulopathy (SCARLET): an updated meta-analysis. Crit Care, 23(1), 302. https://doi.org/10.1186/s13054-019-2587-2
Yamakawa, Kazuma, Jerrold H. Levy, and Toshiaki Iba. “Recombinant human soluble thrombomodulin in patients with sepsis-associated coagulopathy (SCARLET): an updated meta-analysis.Crit Care 23, no. 1 (September 5, 2019): 302. https://doi.org/10.1186/s13054-019-2587-2.
Yamakawa, Kazuma, et al. “Recombinant human soluble thrombomodulin in patients with sepsis-associated coagulopathy (SCARLET): an updated meta-analysis.Crit Care, vol. 23, no. 1, Sept. 2019, p. 302. Pubmed, doi:10.1186/s13054-019-2587-2.

Published In

Crit Care

DOI

EISSN

1466-609X

Publication Date

September 5, 2019

Volume

23

Issue

1

Start / End Page

302

Location

England

Related Subject Headings

  • Thrombomodulin
  • Sepsis
  • Humans
  • Emergency & Critical Care Medicine
  • Disseminated Intravascular Coagulation
  • Blood Coagulation Disorders
  • 42 Health sciences
  • 32 Biomedical and clinical sciences
  • 11 Medical and Health Sciences